Which patients with rheumatoid arthritis are still working?
In the light of improved and costly treatment for rheumatoid arthritis (RA), the evaluation of work disability has gained increased attention. The assumption that better treatment of RA leads to increased work participation has not yet been supported by sufficient evidence. Differences in RA-related work disability have been observed between countries, also indicating an influence of non-disease-related macroeconomic factors. Work disability results from a complex interaction between a clinical disease, sociodemographic variables, macroeconomic conditions, and personal factors. Some of these factors are modifiable, while others are not.
Uhlig
Till
T
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology*; D004185:Disability Evaluation; D006233:Persons with Disabilities; D004467:Economics; D004651:Employment; D006304:Health Status; D006801:Humans; D011788:Quality of Life; D012720:Severity of Illness Index; D012959:Socioeconomic Factors; D016896:Treatment Outcome
D018501:Antirheumatic Agents